Gilbert Kliman MD
Dr. Gil Kliman heads medical device investing for InterWest Partners, a diversified venture capital fund with over $2B under management. He invests in a broad array of life sciences opportunities with a special interest in ophthalmology and medical devices. He has been a major investor in Epocrates (EPOC), Glaukos, IntraLase (ILSE), LenSx Lasers, Neuronetics, NeuroPace, On Demand Therapeutics, Restoration Robotics, and ReVision Optics. Prior to InterWest, Dr. Kliman was a healthcare investor at TA Associates and at Norwest Venture Capital. As a practicing ophthalmologist he was the former west coast director of LCA Vision, and served on the clinical faculty at Tufts New England Eye Center and Massachusetts Eye and Ear Infirmary.
Dr. Kliman has a B.A. from Harvard University. He received an M.D. from the University of Pennsylvania and an M.B.A. from Stanford University. He completed ophthalmology residency at Wills Eye Hospital and a retina laser fellowship at Massachusetts Eye and Ear Infirmary as a Heed Fellow. He also serves as a National Trustee for the Foundation Fighting Blindness.